Kirsten Rat Sarcoma Viral Oncogene Homolog ( <scp>KRAS</scp> ) Mutation Testing Trends, Prevalence, and Outcomes in Metastatic, Non‐Squamous Non‐Small Cell Lung Cancer (Non‐ <scp>SQ NSCLC</scp> ) Patients in Queensland, Australia From 2014–2023

This study is the largest longitudinal analysis of KRASM testing conducted in Australia, with significant improvement in testing rates seen over the time period. Rates of KRASM and characteristics of Australian KRAS mt patients correspond with published literature.